122 related articles for article (PubMed ID: 3754599)
61. Aromatase inactivation by a suicide substrate, androst-5-ene-4,7,17-trione: the 5beta,6beta-epoxy-19-oxo derivative, as a possible reactive electrophile irreversibly binding to the active site.
Numazawa M; Tachibana M
Biol Pharm Bull; 1997 May; 20(5):490-5. PubMed ID: 9178927
[TBL] [Abstract][Full Text] [Related]
62. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
el Etreby MF
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):565-72. PubMed ID: 7682838
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of androgen aromatization in human breast cancer.
Abul-Hajj YJ
J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
[No Abstract] [Full Text] [Related]
64. Synthesis and properties of the epimeric 6-hydroperoxyandrostenediones, new substrates/inhibitors of human placental aromatase.
Tan L; Hrycay EG; Matsumoto K
J Steroid Biochem; 1983 Sep; 19(3):1329-38. PubMed ID: 6621039
[TBL] [Abstract][Full Text] [Related]
65. Characterization of oviductal aromatase in the northern leopard frog, Rana pipiens.
Kobayashi F; Zimniski SJ; Smalley KN
Comp Biochem Physiol B Biochem Mol Biol; 1996 Mar; 113(3):653-7. PubMed ID: 8829814
[TBL] [Abstract][Full Text] [Related]
66. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
Covey DF; Hood WF; Beusen DD; Carrell HL
Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
[TBL] [Abstract][Full Text] [Related]
67. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
68. 19-Oxygenation of C19-steroids with an A, B-ring enone structure, competitive inhibitors of estrogen biosynthesis, with human placental aromatase.
Numazawa M; Yamada K; Nagaoka M
Biol Pharm Bull; 2001 Apr; 24(4):332-5. PubMed ID: 11305590
[TBL] [Abstract][Full Text] [Related]
69. Structure-activity relationships for non-steroidal inhibitors of aromatase.
Banting L; Smith HJ; James M; Jones G; Nazareth W; Nicholls PJ; Hewlins MJ; Rowlands MG
J Enzyme Inhib; 1988; 2(3):215-29. PubMed ID: 3241182
[TBL] [Abstract][Full Text] [Related]
70. Biochemical and pharmacological development of steroidal inhibitors of aromatase.
Brueggemeier RW; Li PK; Chen HH; Moh PP; Katlic NE
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):379-85. PubMed ID: 2257241
[TBL] [Abstract][Full Text] [Related]
71. Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions.
Numazawa M; Handa W; Hasegawa C; Takahashi M
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):353-9. PubMed ID: 16209922
[TBL] [Abstract][Full Text] [Related]
72. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
[TBL] [Abstract][Full Text] [Related]
73. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM
J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of human placental aromatase by novel homologated 19-oxiranyl and 19-thiiranyl steroids.
Childers WE; Silverton JV; Kellis JT; Vickery LE; Robinson CH
J Med Chem; 1991 Apr; 34(4):1344-9. PubMed ID: 2016709
[TBL] [Abstract][Full Text] [Related]
75. A radiometric assay method for aromatase activity using [1 beta-3H]16 alpha-hydroxyandrostenedione.
Numazawa M; Mutsumi A; Nakakoshi M; Nagaoka M
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1839-42. PubMed ID: 1394701
[TBL] [Abstract][Full Text] [Related]
76. Preparation of [1,2-3H,4-14C]16 alpha-hydroxyandrostenedione and its use for radiometric determination of human placental aromatase activity.
Numazawa M; Tsuji M; Yarborough C; Osawa Y
Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2448-52. PubMed ID: 3664841
[No Abstract] [Full Text] [Related]
77. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
Numazawa M; Oshibe M
J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Kellis JT; Vickery LE
Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
[TBL] [Abstract][Full Text] [Related]
79. 6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors.
Numazawa M; Mutsumi A
Biochem Biophys Res Commun; 1991 May; 177(1):401-6. PubMed ID: 2043124
[TBL] [Abstract][Full Text] [Related]
80. Studies of the time-dependent inactivation of aromatase by 4beta,5beta-epoxy-6-one and 5beta,6beta-epoxy-4-one steroids under various conditions.
Numazawa M; Yamada K
Biol Pharm Bull; 1999 Nov; 22(11):1207-11. PubMed ID: 10598029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
